Skip to main navigation Skip to search Skip to main content

Peptidases in autophagy are therapeutic targets for Leishmaniasis

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    Differentiation of Leishmania life forms is crucial for progression and preadaptation of the parasite to the environmental conditions existing in its hosts. Autophagy is a catabolic degradation process that utilizes cytosolic ATG4s and lysosomal cathepsins to affect protein turnover and remodeling, which are crucial for parasite development, differentiation, and virulence. In this chapter, published data on the physiological roles of the cysteine peptidases involved in autophagy and virulence in Leishmania spp. that establishes them as therapeutic targets will be reviewed. Potential lead compounds that can modulate the activities of the cysteine peptidases for therapeutic advantage, the challenges involved, and the opportunities they provide for drug development to control leishmaniasis will be discussed.
    Original languageEnglish
    Title of host publicationTrypanosomatid Diseases
    Subtitle of host publicationMolecular Routes to Drug Discovery
    EditorsTimo Jäger, Oliver Koch, Leopold Flohé
    Place of PublicationWeinheim
    PublisherWiley-VCH Verlag
    Pages351-364
    Number of pages14
    ISBN (Electronic)9783527670383
    ISBN (Print)9783527332557
    DOIs
    Publication statusPublished - 17 Apr 2013

    Publication series

    NameDrug Discovery in Infectious Diseases

    Keywords

    • cysteine peptidase
    • autophagy
    • virulence
    • drug development
    • leishmaniasis
    • cathepsin

    Fingerprint

    Dive into the research topics of 'Peptidases in autophagy are therapeutic targets for Leishmaniasis'. Together they form a unique fingerprint.

    Cite this